Korea Investment CORP Sells 4,400 Shares of Teleflex Incorporated (NYSE:TFX)

Korea Investment CORP decreased its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 25.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,794 shares of the medical technology company's stock after selling 4,400 shares during the period. Korea Investment CORP's holdings in Teleflex were worth $2,277,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Avior Wealth Management LLC grew its stake in shares of Teleflex by 81.2% during the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock valued at $50,000 after purchasing an additional 125 shares during the last quarter. IFP Advisors Inc boosted its position in Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after buying an additional 217 shares during the last quarter. Exchange Traded Concepts LLC increased its stake in shares of Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after buying an additional 94 shares during the period. R Squared Ltd bought a new stake in shares of Teleflex during the fourth quarter worth $64,000. Finally, Kohmann Bosshard Financial Services LLC acquired a new position in shares of Teleflex during the fourth quarter valued at $73,000. Institutional investors own 95.62% of the company's stock.

Teleflex Trading Down 4.4 %

Shares of Teleflex stock traded down $6.06 during trading hours on Friday, hitting $131.93. The company's stock had a trading volume of 1,745,294 shares, compared to its average volume of 593,128. Teleflex Incorporated has a 12 month low of $128.55 and a 12 month high of $249.91. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The company has a market capitalization of $6.12 billion, a PE ratio of 26.23, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The stock has a 50 day moving average of $155.84 and a 200 day moving average of $187.82.

Remove Ads

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. The firm had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.03%. The ex-dividend date was Friday, March 7th. Teleflex's payout ratio is presently 95.77%.

Analyst Upgrades and Downgrades

TFX has been the subject of a number of research reports. Piper Sandler reiterated a "neutral" rating and issued a $140.00 price objective (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Morgan Stanley dropped their price target on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a research note on Wednesday, March 5th. Bank of America cut shares of Teleflex from a "neutral" rating to an "underperform" rating and reduced their price objective for the company from $235.00 to $140.00 in a research note on Tuesday, March 4th. Truist Financial dropped their target price on shares of Teleflex from $200.00 to $149.00 and set a "hold" rating for the company in a research report on Monday, March 3rd. Finally, Needham & Company LLC restated a "hold" rating on shares of Teleflex in a research report on Wednesday, March 12th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, Teleflex has a consensus rating of "Hold" and a consensus price target of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.